Urinary Incontinence and Other Pelvic Floor Dysfunctions in Trail Runners

NCT ID: NCT06469320

Last Updated: 2024-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-25

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The pelvic floor is a crucial complex for many bodily functions, supporting the pelvic organs and contributing to urinary and anal continence, as well as sexual function. Dysfunction of this structure can lead to a variety of disorders, including urinary incontinence (UI), a common problem in women. Although the prevalence of UI in middle-aged women has been documented at between 20% and 30%, high-impact physical activities, such as certain sports and running, increase the risk of UI. According to the most recently published meta-analysis, the prevalence is 44% \[95%CI 30.2-57.8\]. Although this subject is often taboo, it can have psychosocial consequences and affect sporting activities. Only 31.7% of female runners talk to a health professional about it. Trail running, a fast-growing discipline, differs from road running in its particular physical demands, which could influence the occurrence of pelvic floor disorders (PFD) and exercise-induced UTIs. The unique characteristics of trail running, such as the technical nature of the terrain, the steep gradients and the variety of distances, place intense demands on the female pelvi-perineal system. Nevertheless, despite the growing popularity of this sport, little epidemiological data exists on the prevalence of stress UTI and pelvic floor disorders among female trail runners.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Stress Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online questionnaire

Pelvic floor dysfunction assessment questionnaire adapted from PFD-Sentinel

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult runner
* Residing in mainland France, or in French overseas departments and territories such as Guadeloupe, Martinique, French Guiana, Réunion, Mayotte and New Caledonia
* Practising trail running on a regular basis (defined pragmatically by the participant herself), whether or not affiliated to a club
* Able to complete the questionnaire online-

Exclusion Criteria

* Pregnant or have given birth in the last six months
* Does not understand French
* A protected adult (guardianship or curatorship) or under court protection
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas Bouscaren, MD

Role: PRINCIPAL_INVESTIGATOR

CHU La Réunion

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU la Réunion

Saint-Denis, , Reunion

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Reunion

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicolas Bouscaren, MD

Role: CONTACT

+262 (0)2 62 35 90 00

Laetitia Berly, PhD

Role: CONTACT

+262 262906286

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicolas BOUSCAREN, MD

Role: primary

Laetitia BERLY, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/CHU/13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.